Drug regulations

DRUG REGULATIONS NEWS

On the cough syrup row, we need to zoom out — and look at commercial drivers

November 10, 2025 11:23 am

Medicine manufacturers in other countries have also been incriminated for similar adverse events. Three hundred and twenty-three cases of Acute Kidney Injury (AKI) and 190 deaths were reported in Indonesia as recently as 2023, and six pharmaceutical companies were prosecuted for negligence.

Cough syrup deaths: A regulator cannot bust spurious drug rackets. Task needs police involvement

October 07, 2025 1:09 pm

The Drug Control Department possesses domain knowledge, while the police offer operational capability, intelligence gathering, and prosecutorial experience. Convergence of regulatory and criminal law will ensure that enforcement does not stop at compliance checks but extends to dismantling criminal enterprises

Pan D, Shelcal 500 among drug samples flagged by regulator as spurious, 49 others as sub-standard

October 26, 2024 10:20 am

The survey was part of a routine exercise by the drug regulator during which medicines are randomly tested for quality.

Kerala regulator finds three drugs to be of substandard quality

November 11, 2018 7:08 am

The three medicines are of Sanofi India, Macleods Pharmaceuticals and Cadila Healthcare

Drug regulatory provisions: Advisory Board suggests measures to ensure uniform implementation

July 04, 2017 2:17 am

The DTAB suggested the health ministry that each state’s drug-controlling authority should create an intelligence cell with a nodal officer for market surveillance and conducting investigation related to spurious or adulterated drugs.

Advertisement
Advertisement
Advertisement